06/15/18 11:16 AM H.R. 2851
On passage Roll Call 268 - Recorded vote pending.
06/15/18 11:15 AM H.R. 2851
The House adopted the amendment in the nature of a substitute as agreed to by the Committee of the Whole House on the state of the Union.
06/15/18 11:15 AM H.R. 2851
The previous question was ordered pursuant to the rule.
06/15/18 11:15 AM H.R. 2851
The House rose from the Committee of the Whole House on the state of the Union to report H.R. 2851.
06/15/18 11:14 AM H.R. 2851
On agreeing to the Thornberry amendment; Agreed to by recorded vote: (Roll no. 267).
06/15/18 11:14 AM H.R. 2851
On agreeing to the Thornberry amendment; Agreed to by recorded vote: 223 - 158 (Roll no. 267).
06/15/18 10:49 AM H.R. 2851
On agreeing to the Thornberry amendment (A004) Roll Call 267 - Recorded vote pending.
06/15/18 10:37 AM H.R. 2851
DEBATE - Pursuant to the provisions of H. Res. 934, the Committee of the Whole proceeded with 10 minutes of debate on the Thornberry amendment No. 4.
06/15/18 10:37 AM H.R. 2851
An amendment, offered by Mr. Thornberry, numbered 4 printed in Part A of House Report 115-751 to specify the factors to determine whether a controlled substance analogue is intended for human consumption, thus making it easier for law enforcement and health officials to take action against synthetic drug manufacturers, distributors, and sellers.
06/15/18 10:37 AM H.R. 2851
Amendment offered by Mr. Thornberry.
